The Secretome Derived From Serum‐Free Media of SHED ‐ MSCs Can Modulate THP ‐1‐Derived Macrophage Cells
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Azadeh Mohammad-Hasani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Research Centre, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran. Hauptthemen laut MEDLINE: Macrophages, Mesenchymal Stem Cells, Secretome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Golestan University of Medical Sciences.
Abstract (Originalsprache)
Although culturing cells in serum‐free or low‐serum media may lead to reduced cell proliferation, it is crucial to minimise the presence of foreign proteins and other impurities that could compromise the validity of experimental findings on immunomodulation. The study aimed to investigate the immunomodulatory effects of the secretome derived from the serum‐free media (SFM) of stem cells obtained from human exfoliated deciduous teeth on THP‐1‐derived macrophage polarisation and the assessment of inflammatory and oxidative stress mediators. THP‐1 cells were polarised into M0 and M1 macrophages, and their differentiation was confirmed using flow cytometry to analyse specific markers of M0 (CD14 and CD68) and M1 (CD80 and CD86). The secretome was collected from SHED‐MSCs cultured for 48 h in serum‐free DMEM/F12 media. After treating THP‐1‐derived M0/M1 macrophages with SFM‐secretome from SHED‐MSCs, cells and supernatants were evaluated for immunosuppressive (anti‐inflammatory and antioxidant) and immunostimulatory (pro‐inflammatory and pro‐oxidant) indicators. Secretome treatment decreased the population of M1 macrophages, along with the expression of pro‐inflammatory and pro‐oxidative markers, including CD80, CD86, TNF‐α, IL‐12, NO, MDA and IL‐6R. The immunomodulatory effect of the secretome produced by SFM, which may help reduce inflammation, is demonstrated by an increase in M2 macrophages and anti‐inflammatory and antioxidant markers, including CD206, TGFβ‐2, IL‐10, TAC, CAT, SOD and ARG1. The secretome produced by SFM‐derived SHED‐MSCs may reduce the risk of introducing foreign proteins and other potentially hazardous chemicals and enhance the efficacy of cellular secretions for applications such as immunotherapy or regenerative medicine by modulating the immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell Research Centre, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.
- Department of Molecular Medicine, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran.
- Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.
- Department of Immunology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
- Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran.
ORCID-Profile: Ayyoob Khosravi
Förderung
- Golestan University of Medical Sciences
Zitieren
APA
Mohammad-Hasani, A., Mohammadi, S., Saeidi, M., Fallah, A., & Khosravi, A. (2026). The Secretome Derived From Serum‐Free Media of SHED ‐ MSCs Can Modulate THP ‐1‐Derived Macrophage Cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71063
Vancouver
Mohammad-Hasani A, Mohammadi S, Saeidi M, Fallah A, Khosravi A. The Secretome Derived From Serum‐Free Media of SHED ‐ MSCs Can Modulate THP ‐1‐Derived Macrophage Cells. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71063
BibTeX
@article{MohammadHasani2026,
author = {Mohammad-Hasani, Azadeh and Mohammadi, Saeed and Saeidi, Mohsen and Fallah, Ali and Khosravi, Ayyoob},
title = {The Secretome Derived From Serum‐Free Media of SHED ‐ MSCs Can Modulate THP ‐1‐Derived Macrophage Cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71063}
}
EUVIMED